Should investors run from a biotech stock that blows up, taking a one-day dive of 25 percent or more? Or should they add more shares? What about jumping aboard the biotech pop-ups – the companies that see a gain of 25 percent or more in a single day? Read More
The term “big data” captures our imagination – conjuring up supercomputers crunching numbers that spit out information that will set drug developers on the right development path toward exciting new blockbuster medicines. Being able to harness and mine the utility of big data will be critical for innovative drug development going forward. Read More
